ZYXIQ

ZYNEX INC
—

Company Information

Company Name
ZYNEX INC
CIK
CIK0000846475
Category
Accelerated filer<br>Smaller reporting company
Ticker: Exchange
ZYXIQ: OTC
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
3845
SIC Description
Electromedical & Electrotherapeutic Apparatus
Ticker
ZYXIQ

SEC filing data through

Insider Sentiment

Last purchase
2024-07-29
Last sale
2025-03-03
Shares purchased (TTM)
7,000
Shares sold (TTM)
81,083
Buy ratio (TTM)7.9%

Institutional Sentiment

As of
2025-12-31
Institutional shares owned
206,281
Shares outstanding
30,314,000
Ownership
0.68%
-23.41% Y/Y

Earnings Market Reaction

Filing date
2025-11-17
Price on filing date
—
1-month reaction
29.82%
3-month reaction
…
Drift continued6/11 (55%)
Faded / reversed5/11 (45%)

Balance Sheet

Values in millions ($)
Line item2025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-31Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash131824403831334543591720
Short Term Investments--------10---
Accounts Receivable Net Current71014182224252733333235
Inventory Net121214141615151314141413
Prepaid Expense And Other Assets Current565434433221
Assets Current37465675787478881031086570
Property Plant And Equipment Net133333332222
Operating Lease Right Of Use Asset69910111112131331213
Finance Lease Right Of Use Asset111111111000
Deposits Assets Noncurrent000000000111
Intangible Assets Net Excluding Goodwill-77778888999
Goodwill-2020202020202020202020
Deferred Income Tax Assets Net--8554443222
Assets4586106122126122126137151153111116
Liabilities Current
Accounts Payable And Accrued Liabilities Current13787981088666
Dividends Payable Current---------000
Operating Lease Liability Current444444443222
Finance Lease Liability Current000000000000
Accrued Income Taxes Current----0-112022
Short Term Borrowings---------055
Convertible Notes Payable Current5959----------
Employee Related Liabilities Current334566767666
Liabilities Current797416172018221920142121
Long Term Debt----------45
Liabilities Noncurrent
Convertible Debt Noncurrent--5959585858585757--
Business Combination Contingent Consideration Liability---------7910
Operating Lease Liability Noncurrent78910111213141541314
Finance Lease Liability Noncurrent111111000000
Deferred Income Tax Liabilities Net-2----------
Liabilities878585869089939193904750
Preferred Stock Value----------0-
Stockholders Equity
Common Stock Value000000000000
Additional Paid In Capital Common Stock949493939392919191838282
Treasury Stock Common Value-92-92-92-87-87-87-85-72-58-43-37-33
Retained Earnings Accumulated Deficit-44-119303028272726221917
Stockholders Equity-41121363633334659626466
Liabilities And Stockholders Equity4586106122126122126137151153111116
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Preferred Stock Shares Authorized101010101010101010101010
Preferred Stock Shares Issued0000-0000000
Preferred Stock Shares Outstanding0000-0000000
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized100100100100100100100100100100100100
Common Stock Shares Issued424242424242424242424242
Shares Outstanding303030323232323334363737
Treasury Stock Common Shares1212121010101097544

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

ZYNEX INC (ZYXIQ) — SEC Financial Statements & Analysis

ZYNEX INC (ZYXIQ) is a electromedical & electrotherapeutic apparatus company, incorporated in NV. ZYNEX INC trades on OTC as: ZYXIQ. ZYNEX INC (ZYXIQ)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-17. Based on that filing, On profitability, ZYNEX INC posts a gross margin of 71.64%, an operating margin of -62.76%, a net margin of -68.35%, a Return on Equity (ROE) of 2641.83%, a Return on Assets (ROA) of -86.31%, and a Return on Invested Capital (ROIC) of -195.88%. Per share, it reports EPS of $-2.44, diluted EPS of $-2.44, free cash flow per share of $-0.69, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -44.13% year-over-year, net income growth of -1633.13% year-over-year, and EPS growth of -1707.02% year-over-year. On the balance sheet, it maintains a current ratio of 0.47x, a quick ratio of 0.25x, working capital of $-41.83M, a debt-to-equity ratio of -2.10x, a debt ratio of 1.91, an interest coverage ratio of -22.32x, free cash flow of $-21.00M (TTM), and net debt of $47.00M. Figures sourced from SEC EDGAR.

EPS TTM
$-2.44
ROE TTM
2641.83%
ROA TTM
-86.31%
Debt To Equity
-2.10x
Free Cash Flow TTM
$-21.00M
Net Revenue TTM Growth 1Y
-44.13%

Data as of 2025-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ZYNEX INC in?

ZYNEX INC (ZYXIQ) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What exchange does ZYXIQ trade on?

ZYNEX INC (ZYXIQ) trades on the OTC.

Where is ZYNEX INC incorporated?

ZYNEX INC is incorporated in NV.

When was ZYNEX INC (ZYXIQ)'s most recent SEC filing?

ZYNEX INC (ZYXIQ)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-17.

What is ZYXIQ's EPS (earnings per share)?

ZYNEX INC (ZYXIQ)'s trailing twelve month EPS is $-2.44 as of 2025-09-30.

What is ZYXIQ's ROE (return on equity)?

ZYNEX INC (ZYXIQ)'s trailing twelve month Return on Equity (ROE) is 2641.83% as of 2025-09-30.

What is ZYXIQ's ROA (return on assets)?

ZYNEX INC (ZYXIQ)'s trailing twelve month Return on Assets (ROA) is -86.31% as of 2025-09-30.

What is ZYXIQ's ROIC (return on invested capital)?

ZYNEX INC (ZYXIQ)'s trailing twelve month Return on Invested Capital (ROIC) is -195.88% as of 2025-09-30.

Wall Street's data.
Main Street's price.